We are live on
!
Find out more
1IA
1620 Investment Advisors Portfolio holdings
AUM
$161M
1-Year Est. Return
30.15%
This Fund
S&P 500
This Quarter
Est. Return
+6.11%
1 Year Est. Return
+30.15%
3 Year Est. Return
+68.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
+$10.4M
(+7.9%)
Cap. Flow
+$4.06M
Cap. Flow
% of AUM
2.88%
Top 10 Holdings %
Top 10 Hldgs %
21.13%
Holding
722
New
35
Increased
183
Reduced
192
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHR
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$688K |
| 2 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$624K |
| 3 |
T. Rowe Price Floating Rate ETF
TFLR
|
+$531K |
| 4 |
Seagate
STX
|
+$521K |
| 5 |
Medtronic
MDT
|
+$470K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$542K |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$449K |
| 3 |
NSA
National Storage Affiliates Trust
NSA
|
+$415K |
| 4 |
NVIDIA
NVDA
|
+$402K |
| 5 |
Caterpillar
CAT
|
+$283K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.02% |
| 2 | Financials | 11.06% |
| 3 | Healthcare | 7.62% |
| 4 | Consumer Discretionary | 7.29% |
| 5 | Industrials | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Schwab U.S Small- Cap ETF
SCHA
$23.1B
| – | – |
-338
| Closed | -$7.92K |
|
702
Schwab US Large- Cap ETF
SCHX
$74.5B
| – | – |
-444
| Closed | -$9.8K |
|
703
Synopsys
SNPS
$79.7B
| – | – |
-2
| Closed | -$895 |
|
704
Simon Property Group
SPG
$72.3B
| – | – |
-14
| Closed | -$2.33K |
|
|
SPYM
705
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
| – | – |
-38
| Closed | -$2.5K |
|
706
StoneCo
STNE
$2.58B
| – | – |
-26
| Closed | -$272 |
|
707
Tandem Diabetes Care
TNDM
$1.56B
| – | – |
-25
| Closed | -$479 |
|
|
TSVT
708
DELISTED
2seventy bio
TSVT
| – | – |
-16
| Closed | -$79 |
|
709
Unilever
UL
$136B
| – | – |
-484
| Closed | -$32.5K |
|
710
Vivani Medical
VANI
$122M
| – | – |
-9
| Closed | -$9 |
|
711
X4 Pharmaceuticals
XFOR
$460M
| – | – |
-333
| Closed | -$2.36K |
|
|
BERY
712
DELISTED
Berry Global Group, Inc.
BERY
| – | – |
-628
| Closed | -$43.8K |
|
|
PDCO
713
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-14,381
| Closed | -$449K |
|
|
SGYP
714
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| – | – |
-25
| Closed | – |
|
Similar funds
CCW
FC
GPA
SWMG
FPWM
LIM
RCWM
AXA
1620 Investment Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, 1620 Investment Advisors held 722 positions worth $141M, up 7.9% from $131M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
1620 Investment Advisors's Q2 2025 filing shows 35 new, 183 increased, 192 reduced and 41 closed positions. Its largest new stake was T. Rowe Price Floating Rate ETF: 10,412 shares worth $535K. The largest sale was Microchip Technology, an estimated $542K.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
- 1620 Investment Advisors's largest Q2 2025 buy was T. Rowe Price Floating Rate ETF: 10,412 shares worth $535K.
- 1620 Investment Advisors added most to Schwab Intermediately-Term US Treasury ETF in Q2 2025, an estimated $688K increase.
- 1620 Investment Advisors's biggest Q2 2025 reduction was Microchip Technology, cutting an estimated $542K.
- 1620 Investment Advisors fully exited Patterson Companies, Inc. in Q2 2025, selling an estimated $449K.
- 1620 Investment Advisors's ten largest holdings make up 21% of its $141M portfolio in Q2 2025.
- 1620 Investment Advisors opened 35 new positions and closed 41 in Q2 2025.
- 1620 Investment Advisors's portfolio value rose 7.9% quarter-over-quarter to $141M.
Based on 1620 Investment Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.